• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ENL
Click for more information
0.00% 14.0¢

ENLITIC INC. - Charts / Financials

Market Cap $11.02M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Enlitic, Inc. is a healthcare information technology (IT) company that uses Artificial... Enlitic, Inc. is a healthcare information technology (IT) company that uses Artificial Intelligence (AI) in applications to address issues plaguing the delivery of healthcare. Enlitic Curie is the Company's foundational platform that uses AI to unlock the value of the customer's data in real time. ENDEX, the Company's software application powered by the Curie platform, improves every aspect of workflow for radiologists. ENDEX conforms health system data to consistent clinical standards, enables relevant linkage across different care systems, uses AI to create hanging protocol displays, improves image routing and orchestration, and automatically standardizes DICOM descriptions before transmission to PACS. The Company's product consists of standarization, anonymization, and real-world evidence (RWE) database.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 14.53pm 11/07/2024 (20 minute delay) ?
Day
Open 14.0¢   Day High 14.0¢   Day Low 14.0¢
Daily Volume 7142
Bids   Sellers
Number Price Volume   Number Price Volume
2 13.5¢ 32407   1 14.0¢ 4268

Directors & Senior Management

Mr. Lawrence B. Gozlan Chairman of the Board
Mr. Michael Sistenich Chief Executive Officer, Director
Mr. Darren Scotti Chief Financial Officer
Mr. Ron Wider Senior Vice President - Strategy and Product
Mr. Dave Wilson Vice President - Marketing and Communications
Mr. John Marshall Chief Revenue Officer
Mr. Sergio Duchini Director
Mr. Riichi Yamada Director
Ms. Lisa Pettigrew Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
14.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $11.02M
Open High Low Value Volume
14.0¢ 14.0¢ 14.0¢ $1K 7.142K

Buyers (Bids)

No. Vol. Price($)
2 32407 13.5¢
 

Sellers (Offers)

Price($) Vol. No.
14.0¢ 4268 1
View Market Depth
Last trade - 14.53pm 11/07/2024 (20 minute delay) ?
Last
14.0¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
14.0¢ 14.0¢ 14.0¢ 1000
Last updated 14.53pm 11/07/2024 ?

Top Stories

ASX Market Open: US inflation hits 3%; local futures indicate fresh all-time-high | 12 July 2024

The local share market is tipped for a second strong day after climbing nearly 1% on Thursday, tipped to rise +0.5%.
Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree Augustus Minerals Ltd has picked up copper up to 35% and gold grading 10 grams per tonne through rock chip sampling in Western Australia.
Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA Golden Deeps Ltd has entered a binding agreement with two other companies to earn up to 80% in projects in the Lachlan Fold Belt.
Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade” Infini Resources (ASX:I88) has unveiled what it believes could be the highest ever soil sample uranium concentrations found in Newfoundland, Canada, at its Portland Creek Project. Shares jumped up 53% to 75cps at lunchtime on Wednesday, boosting the company’s market cap up to $28....
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug Telix has announced its prostate cancer imaging drug Illuccix won't be negatively impacted by proposed changes to the US medicare system.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.